Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Clinical guidelines

Secondary prevention of gastric cancer

The natural history of 'epidemic' intestinal-type gastric cancer provides consistent data that enable clinicians to design multidisciplinary strategies for secondary prevention. A recent paper by Dinis-Ribeiro et al. reports guidelines for the management of patients with precancerous stomach lesions.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1: The OLGA staging systems frame.

References

  1. Correa, P., Haenszel, W., Cuello, C., Tannenbaum, S. & Archer, M. A model for gastric cancer epidemiology. Lancet 2, 58–60 (1975).

    Article  CAS  PubMed  Google Scholar 

  2. Marshall, B. J. & Warren, J. R. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1, 1311–1315 (1984).

    Article  CAS  PubMed  Google Scholar 

  3. Graham, D. Y. & Rugge, M. Clinical practice: diagnosis and evaluation of dyspepsia. J. Clin. Gastroenterol. 44, 167–172 (2010).

    Article  PubMed  PubMed Central  Google Scholar 

  4. Graham, D. Y. & Asaka, M. Eradication of gastric cancer and more efficient gastric cancer surveillance in Japan: two peas in a pod. J. Gastroenterol. 45, 1–8 (2010).

    Article  PubMed  Google Scholar 

  5. Dinis-Ribeiro, M. et al. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy 44, 74–94 (2012).

    Article  CAS  PubMed  Google Scholar 

  6. Rugge, M. et al. Gastritis: the histology report. Dig. Liver Dis. 43 (Suppl. 4), S373–S384 (2011).

    Article  PubMed  Google Scholar 

  7. Agréus, L. et al. Rationale in diagnosis and screening of atrophic gastritis with stomach-specific plasma biomarkers. Scand. J. Gastroenterol. 47, 136–147 (2012).

    Article  PubMed  PubMed Central  Google Scholar 

  8. Price, A. B. The Sydney System: histological division. J. Gastroenterol. Hepatol. 6, 209–222 (1991).

    Article  CAS  PubMed  Google Scholar 

  9. Rugge, M. et al. OLGA staging for gastritis: a tutorial. Dig. Liver Dis. 40, 650–658 (2008).

    Article  CAS  PubMed  Google Scholar 

  10. Rugge, M. et al. Operative link for gastritis assessment vs operative link on intestinal metaplasia assessment. World J. Gastroenterol. 17, 4596–4601 (2011).

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Massimo Rugge.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rugge, M., Fassan, M. & Graham, D. Secondary prevention of gastric cancer. Nat Rev Gastroenterol Hepatol 9, 128–129 (2012). https://doi.org/10.1038/nrgastro.2012.19

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrgastro.2012.19

This article is cited by

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer